- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 05.11.25 | Metro Bank - Strong Q325 demonstrates solid execution | 363 | Metro Bank has announced strong Q325 results, characterised by strong lending growth to higher-margin targeted areas, up 12% versus H125. This targeted lending to corporate/commercial/SME clients has... ► Artikel lesen | ||
| 05.11.25 | bp - Solid Q325 results, portfolio progress | 495 | bp reported Q325 underlying replacement cost (RC) profit of $2.2bn (Q225: $2.4bn), with stronger operating performance partly offset by a higher tax rate (due to regional profit mix changes). Operating... ► Artikel lesen | ||
| 05.11.25 | Sylvania Platinum - Record Q126 production and rising PGM prices | 564 | Sylvania's production in Q126 continued to accelerate, reaching a record high of 24,522oz for 4E platinum group metals (PGMs) and 31,234oz for 6E. Net profit continued to recover thanks to record production... ► Artikel lesen | ||
| 04.11.25 | Cordel Group - Platform for growth | 319 | Cordel's full year results were in line with broker consensus, with 8% revenue growth and a substantial narrowing of the EBITDA loss, despite sluggish decision cycles. More significantly, Cordel's five... ► Artikel lesen | ||
| 04.11.25 | Northern Data Group - Sale of Peak Mining finalised | 747 | Northern Data has agreed terms of the sale of its Peak Mining assets. The initial transaction proceeds will help liquidity in the near term, while the transaction also creates a more attractive set... ► Artikel lesen | ||
| 04.11.25 | Theon International - Progressing to plan | 449 | Theon has reported a solid quarter, with management increasing revenue guidance for FY25 and providing initial revenue guidance for FY26, including 20% organic growth. This provides a strong base to... ► Artikel lesen | ||
| 04.11.25 | Oryzon Genomics - Progress for iadademstat across the board | 302 | Oryzon has announced encouraging updates for iadademstat. In acute myeloid leukaemia (AML), positive data was reported for two programmes, including the lead oncology programme, FRIDA. Updated interim... ► Artikel lesen | ||
| 03.11.25 | Hybrid Air Vehicles - Military options advance | 261 | Hybrid Air Vehicles (HAV) has secured its first military aircraft reservation, with an undisclosed defence contractor reserving three Airlander 10 aircraft. This marks the first breakthrough into HAV's... ► Artikel lesen | ||
| 31.10.25 | SynAct Pharma - Approaching a catalyst-rich period | 346 | SynAct Pharma's Q325 results underscored the company's steady progress on its clinical strategy, led by the ongoing Phase IIb ADVANCE trial evaluating resomelagon as a first-line treatment for rheumatoid... ► Artikel lesen | ||
| 31.10.25 | International Public Partnerships - Responsible, growing and protected | 342 | International Public Partnerships (INPP) had a strong first half of 2025, maintaining solid financial and operational performance while advancing portfolio optimisation and disciplined capital allocation.... ► Artikel lesen | ||
| 31.10.25 | bp - bp updates Bumerangue | 557 | bp has provided an update on its hydrocarbon discovery at the Bumerangue block in the pre-salt Santos Basin, offshore Brazil. While the find was first reported in August, yesterday's confirmation of... ► Artikel lesen | ||
| 30.10.25 | Georgia Capital - Portfolio growth accelerates | 318 | Georgia Capital (GCAP) reported strong Q325 results, with 7.9% quarterly growth in NAV per share (on a total return basis, in Georgian lari), continuing its long-term growth path (five-year NAV CAGR... ► Artikel lesen | ||
| 30.10.25 | VEON - Q3 preview and changes to FY25 estimates | 902 | VEON has provided guidance on its Q325 results, which will be unusually complicated due to charges taken in relation to the Kyivstar listing and the loss on the sale of its 51% stake in Sky Mobile (Beeline)... ► Artikel lesen | ||
| 30.10.25 | Primary Health Properties - A specialist REIT of scale | 632 | Primary Health Properties' (PHP's) £1.6bn accretive acquisition of Assura creates a sector specialist REIT of scale, strongly positioned to profitably deliver the investment that primary healthcare... ► Artikel lesen | ||
| 30.10.25 | DUG Technology - Strong start to the year | 289 | DUG Technology reported Q126 year-on-year revenue growth of 19% and new services project awards growth of 9% y-o-y, maintaining a flat services order book versus end-FY25. Progress with international... ► Artikel lesen | ||
| 30.10.25 | Filtronic - AGM update confirms trading in line | 341 | Filtronic's AGM trading update highlights a strong sales pipeline, rising engagement with both existing and new clients across key markets, and a robust order book. Despite fx headwinds from a weaker... ► Artikel lesen | ||
| 30.10.25 | Datatec - ADR: Underlying EPS up 43% y-o-y | 384 | Datatec reported a strong performance for H126, with adjusted EBITDA growth of 22% y-o-y, adjusted EBITDA margin expansion from 5.9% to 7.0% and 43% growth in underlying EPS (uEPS) to 19.3c. Software... ► Artikel lesen | ||
| 30.10.25 | Datatec - Underlying EPS up 43% y-o-y | 340 | Datatec reported a strong performance for H126, with adjusted EBITDA growth of 22% y-o-y, adjusted EBITDA margin expansion from 5.9% to 7.0% and 43% growth in underlying EPS (uEPS) to 19.3c. Software... ► Artikel lesen | ||
| 29.10.25 | PVA TePla - Lower FY25 guidance but high order intake | 799 | On 24 October, PVA TePla (PVA) reported that project-related delays in the US and Asia, which had already led to lower FY25 sales and EBITDA guidance in Q2, persisted and worsened in Q3. Therefore,... ► Artikel lesen | ||
| 28.10.25 | Foxtons Group - Lettings good, Sales held back short term | 372 | Foxtons Group's Q325 revenue growth was clearly affected by the loss of consumer confidence in the sales market. We, and the company, believe this will probably continue until the end of the year, given... ► Artikel lesen | ||
| 28.10.25 | BB Biotech - Turning milestones into momentum | 982 | BB Biotech (BION) delivered strong Q325 results, underpinned by its focus on innovative biotech companies with differentiated clinical pipelines and promising long-term potential. NAV increased 24.0%... ► Artikel lesen | ||
| 28.10.25 | Card Factory - It looks like a gift | 350 | Card Factory (CARD) made good progress on its strategy to become a leading global celebrations group in FY25. In the UK, further development of its product categories and space expansion led to market... ► Artikel lesen | ||
| 28.10.25 | SynAct Pharma - Differentiated inflammation resolution approach | 295 | SynAct Pharma is focused on inflammation resolution therapeutics. Its lead asset, resomelagon, is differentiated by its novel mechanism, targeting specific melanocortin receptor subtypes believed to... ► Artikel lesen | ||
| 27.10.25 | LM PAY - Beauty and health without waiting | 396 | LM PAY is a fintech providing consumer finance and 'care now, pay later' solutions via its B2B partnerships with beauty and medical facilities, allowing clients to pre-finance treatments. The company... ► Artikel lesen | ||
| 27.10.25 | Zalaris - Debt refinanced, growth on track | 388 | Zalaris reported record revenue and adjusted EBIT in Q325, with continued growth in the Managed Services business more than offsetting a slower quarter for Zalaris Consulting. The company has secured... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.